Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 20/20 | 0.66 |
| ▸ | AKT2 | P31751 | 20/20 | 0.66 |
| ▸ | AKT3 | Q9Y243 | 20/20 | 0.66 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.64 |
| ▸ | PRKG1 | Q13976 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL192068 | 1.00 | AKT1 (0.66) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL192069 | 1.00 | AKT1 (0.66) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL191318 | 0.91 | AKT1 (0.63) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL191317 | 0.91 | AKT1 (0.63) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL193468 | 0.90 | AKT1 (0.71) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL193467 | 0.90 | AKT1 (0.71) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL192078 | 0.90 | AKT1 (0.64) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL192444 | 0.90 | AKT1 (0.59) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL192443 | 0.90 | AKT1 (0.59) | AKT1AKT2AKT3PIK3CAPRKG1 | |
| SCHEMBL191003 | 0.90 | AKT1 (0.62) | AKT1AKT2AKT3PIK3CAPRKG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2966065-A2 | HYDROXYLATED AND METHOXYLATED CYCLOPENTA [D] PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS | Array Biopharma, Inc. (US) | 2016-01-13 | — | — | EP | disclosed |